GSK Ends Paxil Co-promotion With Mitsubishi Tanabe Subsidiary
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline is ending a co-promotion deal for Paxil (paroxetine) with Mitsubishi Tanabe subsidiary Yoshitomi Yakuhin and will start its own marketing in August